Impact of a multidisciplinary approach on antibiotic consumption, cost and microbial resistance in a Czech hospital
Jazyk angličtina Země Německo Médium print-electronic
Typ dokumentu hodnotící studie, časopisecké články, práce podpořená grantem
- MeSH
- antibakteriální látky ekonomika terapeutické užití MeSH
- bakteriální infekce farmakoterapie MeSH
- bakteriální léková rezistence * MeSH
- délka pobytu statistika a číselné údaje MeSH
- infekce spojené se zdravotní péčí epidemiologie MeSH
- kontrola nákladů MeSH
- lidé MeSH
- mikrobiální testy citlivosti * MeSH
- nemocnice - lůžková kapacita 500 a více MeSH
- nemocnice všeobecné MeSH
- nemocniční informační systémy MeSH
- retrospektivní studie MeSH
- směrnice pro lékařskou praxi jako téma MeSH
- spotřeba léčiv statistika a číselné údaje MeSH
- úspory nákladů MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- hodnotící studie MeSH
- práce podpořená grantem MeSH
- Geografické názvy
- Česká republika MeSH
- Názvy látek
- antibakteriální látky MeSH
OBJECTIVE: The study objective was to evaluate the impact of a restrictive antibiotic policy, efficacy of inpatient therapeutic and prophylactic antibiotic regimens and susceptibility patterns of infecting bacteria in 2000-2004. SETTING: A 500-bed general hospital in the Czech Republic. METHOD: A retrospective computerized survey of antibiotic prescribing practices over a five-year period 2000-2004, using medical records and laboratory data from the hospital information system (HIS). MAIN OUTCOME MEASURE: Consumption of antibiotics expressed in defined daily doses (DDDs) and Euros per 1,000 bed days. Resistance to antibiotics, average length of hospital stay, rate of inpatients treated with antibiotics, number of nosocomial infections per 1,000 bed days, median length of hospital stay and total mortality. RESULTS: Due to a restrictive antibiotic policy implemented in 2002, the use of several antibiotics in 2003 was significantly reduced but the consumption of several other antibiotics rose in 2003. In comparison with 2001 the cost of antibiotic agents (in Euro per 1,000 inpatient days) fell significantly by 31% in 2003 Euro 969.07 vs. Euro 671.34). The hospital saved about Euro 29,288 after the first year of implementation of the new antibiotic policy. The use of restricted antibiotics increased by 8%; however, the expenditure decreased by 26%. For non-restricted antibiotics, the use and expenditure decreased by 71% and 41%, respectively. Consequently, a net reduction of 55% Euro 804.36 vs. Euro 359.36) was achieved. CONCLUSION: The intervention was effective in reducing the use and cost of antibiotics. The HIS is a helpful tool for observing and evaluating the impacts of the measures taken and can be used for assessment of pharmacotherapy outcomes.
Zobrazit více v PubMed
J Clin Pharm Ther. 1999 Jun;24(3):181-9 PubMed
J Antimicrob Chemother. 2005 Apr;55(4):550-7 PubMed
Eur J Clin Microbiol Infect Dis. 2001 Nov;20(11):785-91 PubMed
Int J Antimicrob Agents. 2001 May;17(5):357-63 PubMed
J Antimicrob Chemother. 1996 Dec;38(6):1001-12 PubMed
Scand J Infect Dis. 2001;33(1):63-7 PubMed
Eur J Clin Pharmacol. 2001 Sep;57(6-7):529-34 PubMed
Infect Control Hosp Epidemiol. 1999 Jun;20(6):440-3 PubMed
Clin Microbiol Infect. 1999 Mar;5 Suppl 1:S19-S24 PubMed
Intensive Care Med. 2003 Jan;29(1):49-54 PubMed
Eur J Clin Microbiol Infect Dis. 1997 Dec;16(12):904-12 PubMed
Ann Pharmacother. 2003 May;37(5):646-51 PubMed
J Health Serv Res Policy. 2002 Apr;7(2):111-7 PubMed
Eur J Clin Microbiol Infect Dis. 1990 Jun;9(6):381-9 PubMed
Diagn Microbiol Infect Dis. 1995 May-Jun;22(1-2):239-42 PubMed
